These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7705374

  • 1. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients.
    Sorva A, Välimäki M, Risteli J, Risteli L, Elfving S, Takkunen H, Tilvis R.
    Eur J Clin Invest; 1994 Dec; 24(12):806-12. PubMed ID: 7705374
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients.
    Björkman M, Sorva A, Risteli J, Tilvis R.
    Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037
    [Abstract] [Full Text] [Related]

  • 3. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Jan; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 4. Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency.
    Björkman MP, Sorva AJ, Risteli J, Tilvis RS.
    J Am Geriatr Soc; 2009 Jun; 57(6):1045-50. PubMed ID: 19473453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
    Schou AJ, Heuck C, Wolthers OD.
    Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial.
    Bjorkman MP, Sorva AJ, Tilvis RS.
    J Nutr Health Aging; 2009 May; 13(5):435-9. PubMed ID: 19390750
    [Abstract] [Full Text] [Related]

  • 8. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H, Ljunggren O, Larsson K, Lindh E, Ljunghall S.
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [Abstract] [Full Text] [Related]

  • 9. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A, Saba E, Smoom R, Bader K, Darwish H.
    Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
    [Abstract] [Full Text] [Related]

  • 10. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
    Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A.
    J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
    [Abstract] [Full Text] [Related]

  • 11. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Feb; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 12. Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism.
    Kristoffersson A, Hultdin J, Holmlund I, Thorsen K, Lorentzon R.
    Int J Sports Med; 1995 Apr; 16(3):145-9. PubMed ID: 7649703
    [Abstract] [Full Text] [Related]

  • 13. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D, Zwolińska D, Bednorz R, Owczarek H, Szymańska A, Nahaczewska W.
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [Abstract] [Full Text] [Related]

  • 14. Bone histomorphometry in celiac disease.
    Arnala I, Kemppainen T, Kröger H, Janatuinen E, Alhava EM.
    Ann Chir Gynaecol; 2001 Jan; 90(2):100-4. PubMed ID: 11459257
    [Abstract] [Full Text] [Related]

  • 15. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S, Chicca S, Pasquali M, Zaraca F, Ballanti P, Taggi F, Coen G, Cinotti GA, Carboni M.
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [Abstract] [Full Text] [Related]

  • 16. Bone turnover in prolonged critical illness: effect of vitamin D.
    Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4623-32. PubMed ID: 14557432
    [Abstract] [Full Text] [Related]

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Nov; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 19. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
    Gram J, Junker P, Nielsen HK, Bollerslev J.
    Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
    [Abstract] [Full Text] [Related]

  • 20. Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients.
    Sato Y, Oizumi K, Kuno H, Kaji M.
    Bone; 1999 Mar; 24(3):271-5. PubMed ID: 10071922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.